SCHEMBL22355391

SCHEMBL22355391

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4ccc(-c5nc(-c6ccccc6)nc6ccccc56)cc4)c3)n2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.71
▸ KMT2A Q03164 4/20 0.71
▸ ATM Q13315 1/20 0.71
▸ WHR1 P49842 1/20 0.54
▸ NUDT1 P36639 3/20 0.49
▸ ADORA2A P29274 2/20 0.49
▸ MAPT P10636 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP1A2 P05177 3/20 0.45
▸ CYP3A4 P08684 3/20 0.45
▸ CYP2C9 P11712 3/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ CLK4 Q9HAZ1 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ NR1I3 Q14994 3/20 0.44
▸ VDR P11473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22483467 1.00 MEN1 (0.71) MEN1KMT2AATMWHR1NUDT1
SCHEMBL24403760 1.00 MEN1 (0.71) MEN1KMT2AATMWHR1NUDT1
SCHEMBL17720984 1.00 MEN1 (0.71) MEN1KMT2AATMWHR1NUDT1
SCHEMBL22483157 0.97 MEN1 (0.67) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18503954 0.97 MEN1 (0.66) MEN1KMT2AATMWHR1NUDT1
SCHEMBL24084022 0.97 MEN1 (0.66) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18717813 0.97 MEN1 (0.71) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18504016 0.95 MEN1 (0.64) MEN1KMT2AATMWHR1NUDT1
SCHEMBL21709032 0.95 MEN1 (0.69) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18503958 0.95 MEN1 (0.63) MEN1KMT2AATMWHR1NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220069240-A1 COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-03 — — US disclosed
US-20210009616-A1 COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD (KR) 2021-01-14 — — US disclosed
US-20200266357-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009616-A1 COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SLC39A14, ORC3, TIMM13 MEN1 260/4885KMT2A 2647/4885ATM 2386/4885
US-20200266357-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 MEN1 3122/4885KMT2A 4378/4885ATM 3601/4885
US-20220069240-A1 COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME ORC3, LAGE3, ERCC1 MEN1 114/4885KMT2A 1074/4885ATM 923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback